S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine. The gene discussed is S100A9; the disease is extranodal nasal NK/T cell lymphoma.